NEW YORK (GenomeWeb) — Courtagen Life Sciences will collaborate with Connecticut Children's Medical Center to identify alterations in genes associated with Autism Spectrum Disorder.

As part of the collaboration, Courtagen will use its targeted sequencing panel, DevSeek to genetically profile patients in the hospital's Autism Neurogenetics Clinic. Courtagen is a privately held genetic testing firm that offers next-generation sequencing and protein immunoassay testing for pediatric neurological disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.